Allergan acquires Serica Technologies Morningside Technology Ventures, Prism VentureWorks, and Ivy Capital Partners are very happy to announce the acquisition of their portfolio company, Serica Systems, Inc. By Allergan, Inc. Serica is a growth-stage medical device company centered on the development of biodegradable silk-structured scaffolds for make use of in tissue regeneration in numerous therapeutic areas. Following a acquisition, Serica became a wholly owned subsidiary of Allergan. Serica Stockholders received an upfront cash payment plus collateral in a fresh company, Alacer Biomedical, Inc. The value of the transaction had not been disclosed.Several characteristics of the individuals and the procedure types were linked to the composite end point in unadjusted analyses . Due to interrelationships among some of those variables, after adjustment, just the sort of procedure , extremes of body-mass index, an inability to walk 200 ft, a past background of deep-vein thrombosis or venous thromboembolism, and a brief history of obstructive sleep apnea were linked to the composite end stage significantly. After adjustment for particular patient characteristics, the chance of the composite end point with laparoscopic Roux-en-Y gastric bypass, in comparison with laparoscopic adaptable gastric banding, was increased by way of a factor of 4.8; the chance of the composite end point with open Roux-en-Y gastric bypass, as compared with laparoscopic adaptable gastric banding, was improved by a aspect of 5.8.